Bacterial adherence and other virulence factors for urinary tract infection
- Alain Meyrier, MD
Alain Meyrier, MD
- Professor of Medicine (Emeritus)
- Université Paris-Descartes, Paris, France
Bacterial adhesion onto mucosal or urothelial cells is an important phenomenon determining bacterial virulence. Infection in the urinary tract is related in part to the ability of bacteria to adhere and colonize the gut, perineum, urethra, bladder, renal pelvicalyceal system, and renal interstitium [1-6]. Adhesion is particularly important when infection occurs in an anatomically normal urinary tract [3,5,6], but it is also important in recurrent cystitis and infection complicating indwelling bladder catheters [7,8].
The pathophysiology of bacterial adhesion in the urinary tract is complex. Uropathogenic Enterobacteriaceae are electronegative and too small to overcome repulsion by the net negative charge of epithelial cells. As a result, bacterial adhesion cannot occur in the absence of fimbriae or other (nonfimbrial) surface adhesion systems. These systems have favorable electrical charge and also promote adhesion via hydrophobicity. Fimbriae allow irreversible attachment to the uroepithelial cell membrane via adhesins [5,6].
This topic review will primarily consider the role of bacterial adhesion as a virulence determinant of Escherichia coli and Proteus mirabilis, the two most common strains responsible for urinary tract infection (UTI). Virulence factors of E. coli are mainly responsible for promoting progression of the organism from the fecal reservoir into the bladder and occasionally the kidney. In comparison, virulence factors of P. mirabilis can induce UTI but are particularly important for the formation of infectious struvite stones.
Bacterial virulence is not related to resistance to antimicrobial drugs. As an example, the most adherent strain of E. coli in the patient's intestinal flora is usually sensitive to most antibiotics.
Multiple host-pathogen interactions are at work in urinary tract infections .
- Schoolrik GK. How Escherichia coli infects the urinary tract. N Engl J Med 1989; 320:804.
- Svanborg Edén C, Hausson S, Jodal U, et al. Host-parasite interaction in the urinary tract. J Infect Dis 1988; 157:421.
- Roberts JA. Etiology and pathophysiology of pyelonephritis. Am J Kidney Dis 1991; 17:1.
- Roberts JA. Bacterial adherence and urinary tract infection. South Med J 1987; 80:347.
- Oelschlaeger TA, Dobrindt U, Hacker J. Virulence factors of uropathogens. Curr Opin Urol 2002; 12:33.
- Mulvey MA. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol 2002; 4:257.
- Roberts JA, Fussell EN, Kaack MB. Bacterial adherence to urethral catheters. J Urol 1990; 144:264.
- Reid G, van der Mei HC, Tieszer C, Busscher HJ. Uropathogenic Escherichia coli adhere to urinary catheters without using fimbriae. FEMS Immunol Med Microbiol 1996; 16:159.
- Nielubowicz GR, Mobley HL. Host-pathogen interactions in urinary tract infection. Nat Rev Urol 2010; 7:430.
- Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4:80.
- Johnson JR, Roberts PL, Stamm WE. P fimbriae and other virulence factors in Escherichia coli urosepsis: association with patients' characteristics. J Infect Dis 1987; 156:225.
- Foxman B, Manning SD, Tallman P, et al. Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared between heterosexual sex partners. Am J Epidemiol 2002; 156:1133.
- Servin AL. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev 2005; 18:264.
- Lane MC, Mobley HL. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int 2007; 72:19.
- Le Bouguénec C, Lalioui L, du Merle L, et al. Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates: PCR assays for detection of Afa adhesins that do or do not recognize Dr blood group antigens. J Clin Microbiol 2001; 39:1738.
- Le Bouguenec C, Archambaud M, Labigne A. Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 1992; 30:1189.
- Kuehn MJ, Heuser J, Normark S, Hultgren SJ. P pili in uropathogenic E. coli are composite fibres with distinct fibrillar adhesive tips. Nature 1992; 356:252.
- Stapleton A, Nudelman E, Clausen H, et al. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest 1992; 90:965.
- Goluszko P, Moseley SL, Truong LD, et al. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J Clin Invest 1997; 99:1662.
- Valle J, Mabbett AN, Ulett GC, et al. UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J Bacteriol 2008; 190:4147.
- Meyrier A, Condamin MC, Fernet M, et al. Frequency of development of early cortical scarring in acute primary pyelonephritis. Kidney Int 1989; 35:696.
- Connell I, Agace W, Klemm P, et al. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 1996; 93:9827.
- Hanson LA. Prognostic indicators in childhood urinary infections. Kidney Int 1982; 21:659.
- Floyd RV, Upton M, Hultgren SJ, et al. Escherichia coli-mediated impairment of ureteric contractility is uropathogenic E. coli specific. J Infect Dis 2012; 206:1589.
- Nicolle LE. Terra incognito: the ureter in urinary tract infection. J Infect Dis 2012; 206:1494.
- Langermann S, Palaszynski S, Barnhart M, et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 1997; 276:607.
- Langermann S, Möllby R, Burlein JE, et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 2000; 181:774.
- Tchesnokova V, Aprikian P, Kisiela D, et al. Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli. Infect Immun 2011; 79:3895.
- Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 2010; 78:568.
- Stapleton AE, Dziura J, Hooton TM, et al. Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc 2012; 87:143.
- Dhakal BK, Kulesus RR, Mulvey MA. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest 2008; 38 Suppl 2:2.
- Schulz WA. Uropathogenic bacteria leave a mark. Lab Invest 2011; 91:816.
- Mobley HL, Island MD, Massad G. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis. Kidney Int Suppl 1994; 47:S129.
- Allison C, Emödy L, Coleman N, Hughes C. The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. J Infect Dis 1994; 169:1155.
- Li X, Lockatell CV, Johnson DE, et al. Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect Immun 2004; 72:66.
- Latham RH, Running K, Stamm WE. Urinary tract infections in young adult women caused by Staphylococcus saprophyticus. JAMA 1983; 250:3063.
- Hovelius B, Mårdh PA. Staphylococcus saprophyticus as a common cause of urinary tract infections. Rev Infect Dis 1984; 6:328.
- Jordan PA, Iravani A, Richard GA, Baer H. Urinary tract infection caused by Staphylococcus saprophyticus. J Infect Dis 1980; 142:510.